-
Study aim
-
Determining the effect of anti-adhesion substances in reducing adhesions after laparoscopic endometriosis surgery
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 60 patients. For randomization, the block randomization method will be used using: www.sealedenvelope.com.
-
Settings and conduct
-
This study will be done at Avicenna fertility center and Kamali hospital in karaj city. Patients with advanced endometriosis who underwent surgery during surgery after releasing the adhesion, the material is placed in the places where the adhesion have been opened (intervention group). No intervention is performed for the control group. And between 3 and 6 months after surgery, they undergo ultrasound and the amount of adhesion is determined by ultrasound and compared between the two groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients referred to Avicenna endometriosis clinic and Kamali hospital in Karaj who are diagnosed with severe endometriosis (stage 3 and 4) according to clinical and sonographic criteria; Women in the age group of 15 to 45 years; Women diagnosed with infertility; Women with chronic cyclic pelvic pain associated with menstruation.Exclusion criteria :Pregnant or lactating women, Having Laparoscopy contraindications (coagulopathy, cirrhosis, unclear anatomy, heart, lung disease)
-
Intervention groups
-
Intervention group: During laparoscopic surgery for endometriosis, after releasing the adhesions and shaving the intestine, the anti-adhesion material (interguard oxidized regenerated cellulose, Samyang biofarm company, Made in Hungary) is placed placed in the parts where the adhesion is opened. Control group: No intervention.
-
Main outcome variables
-
Abdominal and pelvic adhesion using ultrasound, 3-6 months after surgery